Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANVAC vs PANVAC-DC in Resected Metastatic Colorectal Cancer
NCT00103142Phase 2Completed
- Sponsor
- Michael Morse
- Start
- Feb 2005
- Primary completion
- Jun 2009
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of PANVAC in colorectal cancer (CRC), sponsored by Michael Morse. Started Feb 2005; status: completed.
02
Drugs
PANVAC
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00103142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103142.